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ABSTRACT Expression of virulence factors in Staphylococcus aureus is regulated
by a wide range of transcriptional regulators, including proteins and small RNAs
(sRNAs), at the level of transcription and/or translation. The sarA locus consists of
three overlapping transcripts generated from three distinct promoters, all containing
the sarA open reading frame (ORF). The 5= untranslated regions (UTRs) of these
transcripts contain three separate regions ⬃711, 409, and 146 nucleotides (nt)
upstream of the sarA translation start, the functions of which remain unknown. Recent transcriptome-sequencing (RNA-Seq) analysis and subsequent characterization
indicated that two sRNAs, teg49 and teg48, are processed and likely produced from
the sarA P3 and sarA P1 transcripts of the sarA locus, respectively. In this report, we
utilized a variety of sarA promoter mutants and cshA and rnc mutants to ascertain
the contributions of these factors to the generation of teg49. We also deﬁned the
transcriptional regulon of teg49, including virulence genes not regulated by SarA.
Phenotypically, teg49 did not impact bioﬁlm formation or affect overall SarA expression signiﬁcantly. Comparative analyses of RNA-Seq data between the wild-type,
teg49 mutant, and sarA mutant strains indicated that ⬃133 genes are signiﬁcantly
upregulated while 97 are downregulated in a teg49 deletion mutant in a sarAindependent manner. An abscess model of skin infection indicated that the teg49
mutant exhibited a reduced bacterial load compared to the wild-type S. aureus.
Overall, these results suggest that teg49 sRNA has a regulatory role in target gene
regulation independent of SarA. The exact mechanism of this regulation is yet to be
dissected.
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taphylococcus aureus is both a commensal and an opportunistic pathogen that
causes a broad range of human and animal infections. The diseases can range from
acute food poisoning, pneumonia, meningitis, superﬁcial skin infections (e.g., acne,
boils, or cellulitis), arthritis, osteomyelitis, or endocarditis to toxic shock syndrome (1, 2).
Besides demonstrating a capacity to rapidly develop resistance to many antibiotics,
including vancomycin, S. aureus has an ability to thwart the innate host defense
systems, included those provided by neutrophils and macrophages (3, 4). In addition,
staphylococcal infections are common after viral infections. Not surprisingly, S. aureus
infections are frequently associated with high mortality, morbidity, and health-related
costs.
The pathogenesis of S. aureus is a complex process that involves multiple virulence
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factors, speciﬁcally, surface proteins, invasive enzymes and proteases, immunological
disguises, membrane-damaging toxins, exotoxins, and inherent and acquired resistance
to antimicrobial agents (1, 5). The expression of many virulence factors is primarily
controlled by global regulatory systems, including two-component regulatory systems
(TCS) (e.g., agr, lytSR, and saeRS) and transcriptional regulators (e.g., at least 10 SarA
family proteins, tcaR, and sigB) (6–9). Among these, the best characterized are the agr
locus, which represents a prototypic two-component quorum-sensing system (10, 11),
and the sarA locus (12), which can regulate directly and indirectly a large number of
genes involved in virulence, autolysis, bioﬁlm formation, stress responses, antibiotic
resistance, and metabolic processes (6, 8, 13–15).
The sarA locus is a complex regulatory system comprising three promoters (P2, P3,
and P1) that yield three distinct but overlapping transcripts (sarA P2, sarA P3, and sarA
P1), each containing the sarA open reading frame (ORF) (16). The expression of these
transcripts is known to be growth phase dependent, with the P2 and P1 promoters
being A dependent and the B-dependent P3 promoter expressed during the postexponential phase of growth (16, 17). Although the expression of the three transcripts
varies with the growth phase, the overall level of SarA production remains relatively
constant until the cell culture reaches the stationary phase of growth, when SarA
expression appears to be higher, presumably as the summation of SarA translation from
the combined sarA transcripts (18, 19). The complexity of sarA regulation is due in part
to the presence of an unusually long (⬃850-bp) region upstream of the sarA coding
sequence that is required for optimal expression of SarA and its target genes throughout the growth cycle (20).
Recently, it was shown that a number of small RNAs (sRNAs) are involved in the
regulation of virulence genes in various organisms, including S. aureus (21–24). Small
RNAs are classiﬁed based on their target regulation: cis-acting sRNAs, such as in binding
to the complementary mRNA (antisense), or trans-acting, such as those that bind target
RNA or proteins at distal sites (21). There are at least 303 potential sRNAs in various S.
aureus genomes, only 92 of which have been positively conﬁrmed by independent
experimental methods (24, 25). The most studied sRNA in S. aureus is agr RNAIII, which
is the effector of the agr system through competitive binding to mRNA of the target
genes (26), including mgrA, hla, and spa mRNAs (22, 27). There are several wellcharacterized sRNAs, including rsaE, which coordinates the downregulation of oppB and
opp-3A (amino acid and peptide transporter) and sucC (succinyl-coenzyme A synthase)
mRNAs to inhibit translation (28); artR, which is involved in activating alpha toxin
expression by targeting the 5= untranslated region (UTR) of sarT mRNA (29); and sprD,
which represses the translation of sbi mRNA (an immunoglobulin binding protein) (30).
Another unique sRNA is the dual-function PSM-mec gene, which confers methicillin
resistance through the cytolytic toxin PSM␣ and inhibits the translation of agrA mRNA
through 5=-end base pairing (31). Transcriptome-sequencing (RNA-Seq) analysis of the
sarA locus disclosed two sRNAs, teg49 and teg48, with teg49 residing within the sarA
P3 and P1 promoter region and involved in virulence gene expression (25, 32).
In this study, we constructed various sarA promoter and cshA and rnc (RNase III)
mutant strains to understand the mechanism of teg49 generation in S. aureus. We also
evaluated the transcriptome of the teg49 mutant, showing both SarA-dependent and
SarA-independent gene regulation. These results indicated that the overall expression
of SarA and bioﬁlm formation were not signiﬁcantly altered due to deletion of the
teg49 region. RNA-Seq analyses of the teg49 mutant compared to wild-type (wt) and
sarA mutant strains indicated that about 133 upregulated genes and 97 downregulated
genes are speciﬁcally regulated by teg49. RNA-Seq data also revealed that 10 putative
regulatory (e.g., saeRS and rbsU) and 34 putative virulence (e.g., sbi, map, lukSF, coa,
setnM, and smc) genes are regulated by teg49, in addition to a large number of
metabolic genes and genes with unknown functions. Validation of potential teg49regulated genes by quantitative real-time PCR (qRT-PCR) conﬁrmed the validity of the
alteration of gene expression. The in vivo signiﬁcance of the teg49 mutant, along with
the hairpin loop 1 (HP1) mutant, of teg49 was assessed using the murine model of skin
iai.asm.org 2
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FIG 1 Expression of the sarA transcripts and teg49 sRNA from sarA promoter mutants at various phases of growth in S. aureus. (A) Schematic
representation of the sarA locus showing various transcripts (sarA P2, sarA P3, and sarA P1) that originate from the P2, P3, and P1 promoters
(arrows), respectively. The sarA open reading frame is indicated by a box, and the promoters are indicated by small boxes. The numbers of the
promoter locations are based on the start codon (ATG) of the sarA gene. (B) Northern blot analysis of total RNA isolated from the wild-type SH1000
and the various isogenic promoter mutants at various phases of growth recorded as OD600 values (OD600 values of 0.7, 1.1, and 1.5 represent
mid-log, late log, and early stationary phases, respectively). In all the gels, 10 g of total cellular RNA was loaded onto each lane, and the blots
were probed with a 375-bp sarA DNA probe containing the sarA ORF (top) or a 180-bp DNA fragment containing teg49 (middle). The 16S and
23S rRNAs of the ethidium bromide-stained gel used for blotting is also shown as a loading control at the bottom. The spliced images were taken
from different regions of the same image. (C) Western blot analysis for SarA, with anti-SarA antibody, of the wild type, its isogenic promoter
mutants, the sarA mutant, and a complemented mutant. Equivalent amounts of extracts (10 g) from the late exponential phase of growth (OD600
⬇ 1.1) were used to detect SarA protein. (Bottom) A Coomassie blue-stained duplicate-run gel used for blotting is shown as a loading control.

abscess infection; the results indicated that the teg49 mutant showed a reduced
bacterial load in infected skin tissues versus the parental strain. Overall, these results
suggest that teg49 sRNA has a regulatory role in target virulence gene regulation in S.
aureus, although the exact mechanism of its action has yet to be dissected in detail.
RESULTS
Analysis of factors involved in the generation of teg49 sRNA. In prior studies,
Beaume et al. (25) identiﬁed, by RNA-Seq of strain N315, two sRNAs, teg49 and teg48,
within the sarA locus. In subsequent studies, we demonstrated the existence of teg49
and teg48 sRNAs within the sarA locus by Northern blotting and primer extension
studies in strain Newman (32). The teg49 sRNA, located within the sarA P3-P1 promoter
region (Fig. 1A), is 196 nucleotides (nt) in length. To determine precisely the origin of
the teg49 sRNA, we ﬁrst constructed various sarA promoter mutants in the SH1000
background. Accordingly, the ⫺35 and ⫺10 promoter sequences of all three sarA
transcripts, P2, P3, and P1, were altered by site-directed mutagenesis, as shown in Fig. 1A.
Promoter-speciﬁc knockout mutants were then constructed, utilizing the temperaturesensitive origin-of-replication shuttle vector pMAD, and veriﬁed by PCR, DNA sequencing, and Northern analysis, as described in Materials and Methods. To verify the
mutation, we ascertained that the corresponding P2, P3, or P1 transcript was absent or
markedly reduced in the respective promoter mutants (ALC8372 [P2m], ALC8373 [P3m],
and ALC8374 [P1m] mutants) when probed with a fragment containing the sarA ORF
February 2018 Volume 86 Issue 2 e00635-17
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FIG 2 Northern blots of diverse mutants to determine the expression of teg49 and teg23 sRNAs. (A)
Northern blot analysis for the teg49 sRNA in the wild-type JE2 and its isogenic RNase and other putative
mutants as indicated. (B) Northern blot analyses to determine the expression of sRNAs (teg49, teg23, and
teg35) in the wild-type, cshA, hfq, rnc, and complemented rnc strains hybridized with radiolabeled 180-bp
teg49, 190-bp teg23, and 225-bp teg35 probes. A total of 10 g of cellular RNA from the various phases
of growth was loaded onto each lane. An ethidium bromide-stained gel used for blotting, showing 16S
and 23S rRNA bands, is shown as the loading control. The spliced images are taken from different regions
of the same image. The numbers above the gels are OD600 values.

(Fig. 1B, top). These mutants were then analyzed for expression of the teg49 sRNA.
Importantly, a band corresponding to the teg49 sRNA was absent in ALC8373 (the P3
promoter mutant) but was present in ALC8372 (the P2 promoter mutant) and ALC8374
(the P1 promoter mutant), while the restored P3 promoter strain (ALC8441) was able to
reestablish both the P3 sarA mRNA and the teg49 sRNA (Fig. 1B, bottom). These data
indicate that the teg49 transcript likely originates from the P3 sarA mRNA, presumably
via speciﬁc cleavage.
The lack of teg49 in the sarA P3 promoter mutant suggests that the sarA P3
transcript may be processed to yield teg49, a stable sRNA species that can be detected
by Northern, primer extension, and real-time PCR (RT-PCR) analyses (32). One possibility
is that this processing step may involve a speciﬁc endoribonuclease(s). To verify this
possibility, we examined the expression of the teg49 sRNA in putative RNase mutants
in the S. aureus JE2 library from the University of Nebraska (33). As shown in Fig. 2A,
only the RNase III (rnc) mutant of JE2 failed to express teg49 among these putative
RNase mutants, while an elevated level of expression was observed in ΔnrdD (anaerobic
ribonucleotide reductase large subunit; SauUSA300_2551), Δrny (RNaseY; SAOUHSC_
01179), and Δendo-RNase L-PSP (putative endoribonuclease L-PSP; SauUSA300_0474)
mutants. There were no signiﬁcant reductions in the levels of teg49 in nine other
mutants, i.e., ΔSauUSA300_1184 (a conserved hypothetical protein similar to thiamine
binding protein), ΔpnpA (polyribonucleotidyltransferase; SauUSA300_1167), ΔnrdG (anaerobic ribonucleotide reductase small subunit; SauUSA300_2550), ΔSauUSA300_2328 (conserved hypothetical protein), ΔSauUSA300_2021 (S1 RNA binding domain protein Tex),
ΔxseA (exodeoxyribonuclease VII large subunit; SauUSA300_1472), ΔSauUSA300_1692
(conserved hypothetical protein), Δrnr (RNase R, SauUSA300_0764) mutnts and a
February 2018 Volume 86 Issue 2 e00635-17
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control ΔSauUSA300_0308 (putative ABC transporter; permease) mutant. For conﬁrmation, we constructed an rnc deletion mutant, as well as a trans-complemented mutant,
in the SH1000 background. As can be seen in Fig. 2B (top), the expression of teg49 was
markedly diminished in the rnc mutants and was restored to nearly parental level in the
complemented mutant (ALC8445).
In an earlier study, we showed that CshA, a DEAD box RNA helicase, protects sarA
mRNAs from the endoribonuclease cleavage of the mazF toxin in strain Newman (34).
Contrary to the usual role of CshA as part of the degradosome to degrade mRNA, CshA
has been linked to the expression and stability of teg49 and possibly 21 other sRNAs
(out of 85 sRNAs examined), as detected by NanoString analysis in strain Newman (34).
To conﬁrm this ﬁnding in SH1000, we veriﬁed by Northern analysis that expression of
teg49, and also teg23, another sRNA protected by CshA, was diminished in the cshA
mutant versus the parent while expression of teg35, the control sRNA not affected by
CshA (34), was found to be elevated in the cshA mutant versus the parent, as one would
predict if teg35 is processed as part of the degradosome (Fig. 2B, bottom). Hfq, a
chaperone that binds and stabilizes many sRNAs in Gram-negative species, did not
have any major impact on the expression of teg49, teg23, and the control sRNA, teg35
(Fig. 2B). Notably, the expression of teg23 was also diminished in the Δrnc mutant of
SH1000 and was restored to the parental level in the complemented mutant, while rnc
had no effect on the expression of teg35.
Effect of the sarA P3 promoter on SarA expression. The generation of teg49 from
the sarA P3 transcript implied that a P3 promoter mutant would have a dual effect on
reducing expression of sarA P3 mRNA and teg49. In our previous studies (32), our data
seemed to suggest that teg49 may have regulatory activity on its own independent
of sarA. To assess the dual effect of sarA P3 mRNA and teg49 in the P3 promoter
mutant on SarA protein expression, immunoblots of whole-cell lysates of various
promoter mutants, along with the wild-type and P3m revertant strains, were probed
with monoclonal anti-SarA antibody. As shown in Fig. 1C, the P3m promoter mutant
(ALC8373) exhibited a moderate reduction in SarA expression of 30% ⫾ 15% at an
optical density at 600 nm (OD600) of ⬃1.1 compared to the wild type (set at 100%
by ImageJ analysis), while the SarA protein level was restored in the revertant
mutant (ALC8441). As a comparison, there was no signiﬁcant decrease in the SarA
protein level for the P2m promoter mutant (ALC8372) compared to the wild-type
strain. However, a signiﬁcant decrease in the SarA protein level was observed in the
P1m promoter mutant (ALC8374), with a reduction of 75% ⫾ 15% at an OD600 of
⬃1.1 with respect to the wild-type strain (100%). As a control, the sarA deletion
mutant did not exhibit any SarA protein expression, but this defect was restored to
the parental level upon complementation (ALC2732). Together, these data revealed
a moderate decrease in the SarA protein level in a P3 promoter mutant in which the
sarA P3 mRNA and teg49 are absent. Given that the sarA P1 promoter mutant can
express teg49 at a normal level (Fig. 1B), accompanied by signiﬁcantly reduced SarA
expression (Fig. 1C), it is unlikely that SarA is involved in the production of teg49.
Effects of teg49 on the sarA P3 transcript and SarA expression. Given our ﬁnding
on the SarA protein level in the sarA P3 promoter mutant, we wanted to dissect the role
of teg49 in SarA expression. Accordingly, we constructed a 204-bp deletion mutant of
teg49 (ALC7907) (Fig. 3A) and a trans-complemented mutant (ALC7912) by introducing
a xylose-inducible promoter vector, pEPSA5, driving a 196-bp teg49 fragment (32).
While the P1 sarA mRNA can be detected in assorted strains of the teg49 mutant, the
P3 mRNA is noticeably absent in the teg49 mutants (ALC7907 and ALC7910) (Fig. 3B).
To rule out the possibility that deletion of teg49 may disrupt the sarA P3 transcript, we
trans-complemented the Δteg49 strain with the pEPSA5 plasmid driving the expression
of teg49 (ALC7912). As shown in Fig. 3B, this strain expressed both the sarA P1
transcript (591 nt long) and a truncated P3 sarA transcript (⬃650 nt long) due to the
chromosomal teg49 deletion. This result indicated that deletion of teg49 affects the
expression of the sarA P3 transcript and that overexpression of teg49 may help stabilize
iai.asm.org 5
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FIG 3 Expression of sarA transcripts and teg49 sRNA in the teg49 mutant and its derivative strains at various phases of growth in S. aureus. (A)
Schematic representation of the teg49 mutant showing the region deleted to construct the mutant (ALC7907). (B and C) Northern analysis of RNA
isolated from the wild-type SH1000, teg49 mutant (7907), teg49 mutant with pEPSA5 (7910), and teg49 mutant with pEPSA5::teg49 and the sarA
deletion mutant (ALC2732) at different growth phases. The blots were probed with a 375-bp DNA probe containing the open reading frame of
the sarA gene (B) or a 180-bp DNA fragment containing teg49 (C). The 16S and 23S rRNA bands in an ethidium bromide-stained gel served as
loading controls. Various sarA transcripts (P2, P3, and P1) are marked, while P2* and P3* (B) indicate the corresponding truncated transcripts due
to deletion of the teg49 region. P3** (C) denotes the size of the P3 transcript in the sarA mutant of SH1000, where the sarA gene has been replaced
by ermC. The spliced images were taken from different regions of the same image. (D) Western blot analyses for SarA with anti-SarA antibody
of the wild type, the teg49 strain, and its isogenic derivative strains from panels B and C. Equivalent amounts of extracts (10 g) from the different
phases of growth (OD600 ⬇ 1.1, late exponential phase; OD600 ⬇ 1.7, postexponential phase) were used to detect SarA protein. (Bottom) A section
of Coomassie blue-stained duplicate-run gel used for blotting is shown as a loading control for all the gels. All the strains containing pEPSA5 and
its derivatives were grown in the presence of 2% xylose to induce teg49 expression. The numbers at the left of the gels are the OD600 values.

the P3 sarA transcript in a teg49 mutant strain; alternatively, teg49 may somehow affect
sarA P3 promoter activity. As expected, the teg49 transcript was detected in the
trans-complemented teg49 strain (ALC7912), but not in the Δteg49 mutant strain (Fig.
3C). To ascertain if deletion of teg49 would alter SarA protein expression independently
of the sarA P3 promoter activity, we performed Western blot analysis of the whole-cell
lysate from ALC7907 (Δteg49) and its derivative strains containing pEPSA5 (vector;
ALC7910) or the complemented plasmid, pEPSA5::teg49 (ALC7912), along with the wild
type, using monoclonal anti-SarA antibody 1F1. As shown in Fig. 3D, the changes in the
SarA protein level for these strains in two growth phases were not signiﬁcant (15% ⫾
10%), as measured by densitometric scanning with ImageJ. Overall, these results
support the notion that the sarA P3 transcript contributed moderately to the expression
of SarA inside the cell and that teg49 contained within the sarA P3 transcript is not a
major contributor to SarA expression.
Bioﬁlm formation and expression of some virulence genes in the teg49 mutant. Several studies have disclosed the critical role of SarA in regulation of bioﬁlm
formation in Staphylococcus species (13, 35). To determine the role of the teg49 mutant
in bioﬁlm formation, bioﬁlm assays were performed (Fig. 4A). Concordant with a lack of
effect on the SarA protein level, the teg49 mutant exhibited bioﬁlm formation similar
to that of the parental strain, SH1000, and the complemented mutant. Expression of
bioﬁlm-related genes, such as the icaRA genes, was also found not to be affected by
inactivation or overexpression of teg49 (Fig. 4B). Collectively, these data indicate that
teg49 is not a major contributor to bioﬁlm formation in strain SH1000.
February 2018 Volume 86 Issue 2 e00635-17
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FIG 4 Phenotypic and genetic analyses for bioﬁlm formation and selective virulence gene expression for the teg49 mutant
and its derivative strains. (A) Bioﬁlm formation by various strains in microtiter wells containing TSB and 0.25% glucose. The
cells were grown for 24 h, and the bioﬁlms were stained with crystal violet and solubilized with acetic acid to read OD550.
The sarA mutant and complemented mutant were used as negative and positive controls, respectively. The results are
expressed as means and standard errors of the mean. (B) Northern blots for the wild-type, teg49 mutant, teg49 containing
pEPSA5, teg49 mutant containing pEPSA5::teg49, and isogenic sarA mutant strains at various phases of growth. The probes
used for hybridization were icaR and icaA for bioﬁlm phenotype-related genes. (C) Northern blots of the regulatory locus
(agr RNAIII), protein A (spa), ␣-hemolysin (hla), and V8 protease (sspA) genes for the wild-type, teg49 mutant (ALC7907),
teg49 mutant with pEPSA5::teg49 (ALC7912), and isogenic sarA mutant strains from various growth phases as indicated. All the
strains containing pEPSA5 and its derivatives were grown in the presence of 2% xylose for the induction of teg49. A total of 10
g of cellular RNA from various phases of growth was loaded onto each lane. The 23S and 16S rRNAs of an ethidium
bromide-stained gel used for blotting are shown as the loading control. The numbers beside the gels are OD600 values.

The effect of teg49 on virulence genes, such as agr, spa, hla, and sspA, in the SH1000
background was also examined. As shown in Fig. 4C, RNAIII of the agr locus was
moderately increased in the complemented mutant (27% ⫾ 5%) versus the parent (set
at 100%) and the teg49 mutant (9% ⫾ 5%), while RNAIII expression was much lower in
the sarA deletion mutant (56% ⫾ 5%) than in the parental strain, SH1000. However,
the effect of teg49 on spa, hla, and sspA was more subtle, with lower hla expression
and higher spa expression in the teg49 mutant versus the parent; these phenotypes are
inconsistent with higher RNAIII expression. A slight decrease in sspA mRNA was
detected in the mutant versus the parent, concordant with a lack of change in the SarA
protein level in the mutant. As expected, the control sarA deletion mutant expressed
lower levels of agr and hla and higher spa and sspA levels versus the parent (Fig. 4C).
Plate-based phenotypic assays were performed to determine the zone of clearance on
tryptic soy agar (TSA) containing sheep blood to determine the overall hemolysin
activity. As shown in Table 1, there were very slight changes in the zone of clearances
for hemolysis: 15 ⫾ 2 mm for ALC7907 (teg49 mutant) compared to 18 ⫾ 2 mm for the
wild type. Further characterization indicated that there was no growth difference
February 2018 Volume 86 Issue 2 e00635-17

iai.asm.org 7

Manna et al.

Infection and Immunity

TABLE 1 Plate assays for hemolysins and proteases
Zone of clearance (mm)
Straina
SH1000 (wt)
ALC7907 (teg49 KO)
ALC7910 (ALC7907 containing pEPSA5)
ALC7912 (ALC7907 containing pEPSA5 plus teg49)
ALC2732 (sarA KO)
aKO,

Sheep blood agar
18 ⫾ 2
15 ⫾ 2
16 ⫾ 2
15 ⫾ 2
12 ⫾ 2

5% skim milk
5⫾1
4⫾1
4⫾1
5⫾1
15 ⫾ 1.5

knockout.
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between the wild-type and the teg49 mutant strains. In addition, DNA sequence
analysis of the sarA loci of both strains suggested that there were no additional base
changes in the wild-type and teg49 mutant strains. Therefore, the observed results from
these experiments were likely attributable to the deletion of the teg49 region within
the sarA locus.
RNA-Seq analysis of the teg49 mutant. As deletion of teg49 did not signiﬁcantly
alter SarA protein expression and overexpression of teg49 seemed to augment agr
expression independently of SarA, we wanted to gain insight into the overall spectrum
of genes controlled by teg49 via transcriptional proﬁling using Illumina RNA-Seq. To
reﬁne the expression proﬁle of the teg49 mutant, a minimum read value of 50 reads per
kilobase per million (RPKM) and a 4-fold change were considered to reduce the large
number of genes attributable to teg49 deletion. In addition, phage-borne genes were
also eliminated from our analysis. Using 4-fold change as the cutoff, transcriptional
proﬁling by RNA-Seq revealed that 155 genes were upregulated in the teg49 mutant
versus the wild-type strain, while 140 genes were downregulated. As the sarA P3 mRNA
was altered in the teg49 mutant (Fig. 3B), the RNA-Seq proﬁle of teg49 was further
reﬁned by subtracting sarA-mediated genes of SH1000 deduced from the RNA-Seq data
of the sarA mutant. In all, 133 genes were upregulated for expression and 97 genes
were downregulated in the teg49 mutant versus the wild-type strain (see Tables S2
and S3 in the supplemental material). There were 47 increases and 70 decreases in
metabolism- and enzyme-related transcripts, 33 increases and 13 decreases in cell
wall- and transport-related gene products, 40 increases and 3 decreases in mRNAs
involved in cellular processes and regulatory and virulence factors, and 13 increases
and 11 decreases in expression of genes with unknown functions in the teg49 mutant
compared to the wild-type strain. Table 2 shows a few selected categories of genes,
such as those involved in cellular function, regulatory processes, and virulence factors,
that were altered in the teg49 mutant versus the parental strain. Interestingly, two
known regulatory genes (saeRS and lytS), as well as four unknown genes, were
upregulated in the teg49 mutant versus the parent, while three putative regulatory
genes were downregulated. Notably, the saeRS regulatory system, which is not a part
of the sarA regulon, was upregulated (⬃104-fold for saeR and ⬃52-fold for saeS
transcripts) in the teg49 mutant versus the parent, indicating strong saeRS repression
by teg49. The exact role of this regulatory relationship is not clear and is under
investigation. Among 33 upregulated virulence genes in the teg49 mutant, 13 genes
are related to toxins (e.g., hlgA, hlgB, lukS, lukF, SAOUHSC_00354, SAOUHSC_00383,
SAOUHSC_00392 to SAOUHSC_00395, SAOUHSC_01124, SAOUHSC_01125, and
SAOUHSC_01127), 7 genes are related to autolysis and proteases (e.g., lrgA, SAOUHSC_
02166, SAOUHSC_02170, SAOUHSC_02023, SAOUHSC_02019, and SAOUHSC_01576),
and 13 genes are related to cell wall factors (e.g., map, sbi, SAOUHSC_02167,
SAOUHSC_02160, SAOUHSC_01114, SAOUHSC_01115, SAOUHSC_01110, and SAOUHSC_
01112), while the expression of one virulence gene (smc) is reduced among downregulated genes in the teg49 mutant (Table 2). Consistent with our ﬁnding that the SarA
protein level did not change signiﬁcantly between the teg49 mutant and the wild type,
the RNA-Seq data revealed no signiﬁcant differences in the expression of several
well-known sarA-regulated genes between the isogenic mutant strains. For instance,
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TABLE 2 Upregulated and downregulated expression of selected genes in the teg49 mutant versus the wild type
Expression value

Downregulated genes
Cellular process, transcriptional regulators,
and virulence factors
SAOUHSC_01196
SAOUHSC_01204
SAOUHSC_01206
aMHC,

Gene name or description

Wild-type
SH1000

ALC7907 teg49
mutant

Fold
change

Helix-turn-helix domain-containing protein
Transcriptional activator RinB-like protein
Response regulator; SaeR
Mga helix-turn-helix domain protein
Repressor
Sensor histidine kinase; SaeS
Two-component sensor histidine kinase

0
0
298
0
0
425
92

166
143
31,113
72
55
22,405
384

166
143
104.40
72
55
52.72
4.17

Staphylococcal complement inhibitor
Map domain protein
MHCa class II analog protein (Map)
Staphylococcal complement inhibitor; SCIN
Staphylococcal complement inhibitor
Fibrinogen-binding protein
Putative holing-like protein
Immunoglobulin G-binding; Sbi
Peptidoglycan hydrolase
Gamma-hemolysin H-gamma-II subunit; HlgA
Fibrinogen-binding protein-like protein
Formyl peptide receptor-like 1-inhibitory protein
Staphylococcal/streptococcal toxin, beta-grasp domain
Leukocidin F subunit; HlgB
Leukotoxin; LukS
Staphylokinase
Bifunctional autolysin
Autolysin
Exonuclease family protein
Leukotoxin; LukF
Superantigen-like protein 8
Extracellular matrix and plasma binding protein; Ssp
Superantigen-like protein 9
Superantigen-like protein 1
Staphylococcal complement inhibitor
Superantigen-like protein 10
Superantigen-like protein
Superantigen-like protein
Superantigen-like protein 7
Staphylocoagulase; Coa
Superantigen-like protein
Cold shock protein B
Murein hydrolase regulator; LrgA

10
27
30
77
26
26
0
19
0
12
21
34
11
37
84
0
0
0
0
130
4
20
4
27
5
11
10
8
8
7
11
7,372
141

32,147
20,766
20,205
36,003
7,600
7,399
254
3,767
193
1,902
3,142
4,726
1,119
3,416
5,299
55
42
34
27
3,494
91
407
74
464
68
132
100
79
72
46
68
30,223
602

3214.7
769.11
673.5
467.57
292.30
284.57
254
198.26
193
158.5
149.61
139
101.72
92.32
63.08
55
42
34
27
26.87
22.75
20.35
18.5
17.18
13.6
12
10
9.87
9
6.57
6.18
4.09
4.26

Fatty acid biosynthesis transcriptional regulator
SMC domain-containing protein
DNA-binding protein

1,075
209
259

115
35
47

9.34
5.97
5.51

major histocompatibility complex.

some of the regulatory genes known to be repressed by SarA, e.g., sarT (1 versus 2),
sarU (1 versus 1), and sarV (117 versus 93) did not differ in expression read values
(RPKM) between the teg49 mutant and the wild type, implying that there may be two
distinct pathways for the regulation of target genes by SarA and teg49 sRNAs in S.
aureus.
Validating the expression of selective target genes of teg49 sRNA. To validate
our RNA-Seq data, we analyzed by Northern analysis six known and putative genes that
were altered in the teg49 mutant but not in the sarA mutant (SAOUHSC_00401,
SAOUHSC_02160, SAOUHSC_02167, SAOUHSC_02841, saeR, and lytS). As shown in
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Gene designation
Upregulated genes
Cellular process and regulatory systems
SAOUHSC_01575
SAOUHSC_02053
SAOUHSC_00715
SAOUHSC_02077
SAOUHSC_02235
SAOUHSC_00714
SAOUHSC_00230
Virulence factors
SAOUHSC_02167
SAOUHSC_02160
SAOUHSC_02160
SAOUHSC_00401
SAOUHSC_01115
SAOUHSC_01114
SAOUHSC_02166
SAOUHSC_02706
SAOUHSC_02170
SAOUHSC_02708
SAOUHSC_01110
SAOUHSC_01112
SAOUHSC_00354
SAOUHSC_02710
SAOUHSC_02243
SAOUHSC_02171
SAOUHSC_02023
SAOUHSC_02019
SAOUHSC_01576
SAOUHSC_02241
SAOUHSC_00393
SAOUHSC_00816
SAOUHSC-00394
SAOUHSC_00383
SAOUHSC_00191
SAOUHSC_00395
SAOUHSC_01127
SAOUHSC_01125
SAOUHSC_00392
SAOUHSC_00192
SAOUHSC_01124
SAOUHSC_00241
SAOUHSC_00232
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FIG 5 Validation of RNA-Seq data by Northern blot and phenotypic assays. (A) Northern blots of RNA-Seq
data on deduced teg49 target genes, including SAOUHSC_00401 (467-fold upregulated), SAOUHSC_02167
(3,214-fold upregulated), SAOUHSC-02160 (769-fold upregulated), SAOUHSC_02841 (32-fold downregulated), saeR (104-fold upregulated), and lytS (4-fold upregulated) for the wild-type, teg49 mutant (ALC7907),
and isogenic sarA mutant strains at the exponential phase of growth. A total of 10 g of cellular RNA was
loaded onto each lane. The 23S and 16S bands of the ethidium bromide-stained gel used for blotting are
shown as the loading control. The spliced images were taken from different regions of the same image. (B)
Thirteen randomly selected RNA-Seq-analyzed genes, along with the gyrB control, were selected for
qRT-PCR using total RNA isolated from the respective strains at the exponential phase of growth. The data
were normalized against gyrB as the reference transcript for qRT-PCR. All the numbers on the x axis are the
gene names from the S. aureus strain NCTC8325 genome (SAOUHSC). (C) Effect of teg49 inactivation on
penicillin-induced lysis or growth inhibition. Penicillin G-induced lysis of wild-type SH1000, teg49 mutant
(ALC7907), and isogenic sarA mutant (ALC2732 as the control) strains was measured as a decrease in the
optical density at 650 nm over time. Penicillin G (0.04 g/ml, or ⬃10-fold subinhibitory concentration) was
added to early-exponential-phase growing cultures (OD650 ⬇ 0.25), and changes in the OD650 were
monitored over a 7-h period. The percentage of growth inhibition or lysis by penicillin G over time was
plotted and was calculated as the OD over time divided by the OD at the time penicillin G was added
multiplied by 100. The experiments were repeated at least three times. The results are expressed as means
and standard errors of the mean.

Fig. 5A, the expression of the SAOUHSC_401, SAOUHSC_02167, and SAOUHSC_2160
mRNAs was signiﬁcantly elevated in the teg49 mutant versus the wild type, consistent
with the RNA-Seq data (read values of 36,003 versus 77, 32,147 versus 10, and 20,766
versus 27, respectively, for SAOUHSC_401, SAOUHSC_02167, and SAOUHSC_2160)
(Table 2). In contrast, the expression of the SAOUHSC_02841 transcript was reduced in
the teg49 mutant, concordant with a 32-fold reduction in read values (RPKM) in the
teg49 mutant versus the parental strain (see Table S2 in the supplemental material).
Similarly, the expression of two regulatory genes, saeR and lytS, was found to be increased
in the teg49 mutant versus the parent by Northern analysis (Fig. 5A), in agreement with
the results of RNA-Seq (Table 2). To further validate the RNA-Seq results, quantitative
RT-PCR was performed with 13 putative genes, using the gyrB gene as the control (Fig.
5B). Among these analyzed genes, nine were upregulated, as determined by RNA-Seq
(see Table S2 in the supplemental material) (SAOUHSC_02235, SAOUHSC_01575,
SAOUHSC_00383/set1 nm, SAOUHSC_01925, SAOUHSC_01114, SAOUHSC_02708/hlgA,
SAOUHSC_02241/lukF, SAOUHSC_01053/mntH, and SAOUHSC_01942/splA) while four were
downregulated (SAOUHSC_00121/capH, SAOUHSC_00241/rbsU, SAOUHSC_01147/murD,
and SAOUHSC_00158), covering a wide range of genetic pathways ranging from metabolism to proteins with unknown functions (see Table S3 in the supplemental material).
qRT-PCR analysis conﬁrmed changes in gene expression in the teg49 mutant (Fig. 5B),
with the exception of two genes (SAOUHSC_02235 and SAOUHSC_01925) that failed to
produce any product either by qRT-PCR or by normal PCR using the ﬁrst-strand
February 2018 Volume 86 Issue 2 e00635-17
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FIG 6 The teg49 and HP1 mutants exhibited reduced virulence in a mouse model of skin abscess
infection. Mice (6 in each group) were challenged with ⬃1 ⫻ 108 CFU of S. aureus SH1000 or its isogenic
teg49 or HP1 mutant and observed daily for the presence of skin abscesses. Shown are the mean
numbers of colonies counted per gram of infected skin tissue with standard errors of the mean. The
mean counts per gram of tissue for the teg49 and HP1 mutants were considered to be statistically
signiﬁcantly different from that of the parent.

synthesized DNA (cDNA) as the template, indicating that detection of these two
genes by RNA-Seq may be due to artifacts. Thus, Northern blots and qRT-PCR results
validated the RNA-Seq data and indicated that teg49 sRNA has an important role in
regulating the stability of these transcripts. Whether teg49 is involved directly or
indirectly has yet to be determined. The increase in transcript levels for genes encoding
putative autolysin (SAOUHSC_02019 and SAOUHSC_02023), putative peptidoglycan
hydrolase (SAOUHSC_02170), a putative holin-like protein (SAOUHSC_02166), and
regulator-like LrgA in the teg49 mutant (but not in the sarA mutant) suggested that
teg49 may have some role in autolysis of S. aureus. Accordingly, we tested the teg49
mutant for susceptibility to penicillin-induced lysis (Fig. 5C). Penicillin G (0.04 g/ml; the
MIC for strain SH1000 is ⱕ0.004 g/ml) was added to a growing culture at the early
exponential phase of growth (OD650, ⬃0.25), and the OD650 was monitored over a 7-h
period. As shown in Fig. 5C, the teg49 mutant exhibited sensitivity to penicillin-induced
lysis compared to the wild-type SH1000. As a positive control, the sarA mutant
displayed high sensitivity to penicillin-induced lysis, consistent with previously published
data (36). This sensitivity to penicillin-induced lysis in the teg49 mutant is notable because
the SarA protein level in the teg49 mutant was only slightly reduced compared with the
wild type (Fig. 3D). Overall, this phenotypic observation validates the changes in the levels
of transcription of autolysis-related genes in the teg49 mutant compared with the parent.
Murine model of skin abscess with the teg49 mutant. To seek in vivo correlation,
the virulence of the teg49 mutant, along with those of the wild type and the HP1
mutant of teg49 (32), was evaluated in a mouse skin abscess model of infection (Fig. 6).
Using the number of CFU per gram of skin abscess tissue as a readout, the results
indicated that there was a signiﬁcant difference (P ⬇ 0.0272) between the bacterial cell
density of teg49 mutant and those of the wild-type strains at 5 days after initial
infection. Similarly, mutation in HP1 of teg49, a crucial structure of teg49 (32), also
showed a reduced bacterial load (P ⬇ 0.0128) compared to the wild-type strain. It
should be mentioned that, despite the ﬁnding that teg49 did not affect the overall SarA
expression in a signiﬁcant way, RNA-Seq studies suggested that teg49 might affect
virulence genes independently of SarA. This in vivo study using the murine model of
cutaneous abscess seems to support that hypothesis.
DISCUSSION
The discovery of sRNAs in bacteria in the last 2 decades has provided new insights
into gene regulation. sRNAs have been found to be ubiquitous and represent the most
abundant class of posttranscriptional regulators in prokaryotes (21–23). Most of the
sRNAs act by base pairing with target mRNAs. However, the majority of sRNA studies
have been limited to Escherichia coli and other Gram-negative bacteria (23). With the
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exception of RNAIII, most of the sRNA studies in Gram-positive bacteria, including
S. aureus, are not well delineated mechanistically (22). The RNAIII molecule, a 516-ntlong RNA, is an effector molecule of the agr system and activates translation of the hla
gene product (26) and stabilizes mgrA transcripts (27), as well as inhibiting translation
of many transcripts, such as rot, sa1000 (ﬁbrinogen binding protein), sa2261 (ABC
transporter), spa (protein A), lytM (peptidoglycan hydrolase), map (major histocompatibility complex class II-analogous protein), and coa (coagulase) (21, 22). Thus, RNAIII of
the agr system has established the role of sRNA in stability and translation of mRNA in
S. aureus.
Besides agr, sarA is another major regulatory locus involved in the expression of
toxins, enzymes, and cell wall adhesins. The sarA locus is peculiar in that the 372-bp
sarA coding region is preceded by an ⬃850-bp-long 5= UTR that consists of three
distinct promoters, yielding three overlapping transcripts (16, 17). However, complementation studies suggest that the 5= UTR may play an important role in optimal
expression of the SarA protein (20). Recent identiﬁcation of two sRNAs in this region by
RNA-Seq analysis (25) provided the impetus to ascertain the role of sRNA teg49 in gene
regulation in SarA-dependent and SarA-independent manners (32).
In this report, we have shown via mutation analysis of the ⫺35 and ⫺10
promoters of the sarA locus that teg49 is most likely produced and processed from
the P3 sarA transcript (Fig. 1). Most notably, in the absence of teg49 in SH1000, the
transcription of P3 sarA mRNA ceased (Fig. 3B) but was restored upon transcomplementation from a plasmid expressing teg49 in the teg49 mutant (ALC7912),
thus indicating that teg49 has an important role in the stability of the P3 sarA
transcript. Surprisingly, the overall SarA level was, at best, slightly altered (Fig. 3D)
despite the relative absence of the sarA P3 and, to a certain extent, sarA P2
transcripts in the teg49 mutant, signifying that overall SarA expression is mostly
due to the contribution of the P1 sarA transcript in S. aureus. Previous studies have
shown in strain Newman that the production of teg49 was cshA dependent (32).
This result was also conﬁrmed in the SH1000 background. Traditionally, CshA has
been known to be involved in ribosome biogenesis, ribosome assembly, and mRNA
decay in a degradosome involving RNase J, RNase Y, and polynucleotide phosphorylase (PNPase) (37). Our unpublished in vitro assay with puriﬁed CshA and in
vitro-transcribed P3 sarA mRNA demonstrated that CshA can bind the sarA P3
transcript and protect it from endonuclease (e.g., RNase III). In this regard, we
surmise that CshA may be involved in the initial stability and eventual processing
of the sarA P3 transcript by an RNase to yield teg49 sRNA. Surprisingly, inactivation
of Hfq, an sRNA chaperone well described in Gram-negative bacteria, did not yield
any alterations in the levels of transcripts of three analyzed sRNAs (i.e., teg49, teg23,
and teg35). This ﬁnding indicated that Hfq does not have a major role in stabilizing
sRNA in S. aureus, consistent with other reports of Gram-positive bacteria (23).
Analysis of the putative RNase mutants in the JE2 mariner transposon library
indicated that RNase III, an endoribonuclease that cleaves double-stranded RNA (38,
39), may be required for processing of the sarA P3 transcript to produce teg49. The
speciﬁcity of RNase III in this cleavage was demonstrated with teg23, another sRNA
known to be stabilized by CshA, while the control, teg35, an sRNA not stabilized by
CshA (34), was not altered in the rnc mutant. Previous studies have shown that RNase
III is normally involved in regulating the turnover of mRNAs and noncoding RNAs (40,
41). RNase III also likely targets the 5= overlapping regions of divergent mRNAs to
generate species with shorter or even leaderless 5= UTRs (42).
Among several other mutants tested for putative endoribonuclease activity to
cleave sarA P3 mRNA (Fig. 2A), we found that inactivation of the conserved
hypothetical-protein genes (e.g., SauUSA300_1184, SauUSA300_2328, and SauUSA300_
1692), ABC permease gene (SauUSA_308), and polyribonucleotide transferase (pnp)
gene did not have any effect on expression of teg49. Only inactivation of three genes
(nrdD, rny, and endo-RNase L-PSP) showed increased expression; the reason for this
increase is not clear at this point. Notably, RNase E, an important part of the degradoiai.asm.org 12
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some that processes mRNA in many Gram-negative bacteria, is absent in S. aureus,
while RNase Y (encoded by rny), which is involved in processing of monophosphorylated RNA (43), appears to have a role in destabilizing teg49 (Fig. 2A). Collectively, these
results indicated that endoribonucleases are likely involved in the generation and
stabilization of teg49 sRNA. Consistent with a lack of major alteration in the overall level
of the SarA protein, a major player in regulating bioﬁlm formation, in the teg49 mutant,
there was no major change in bioﬁlm formation in the teg49 mutant. It should be noted
that regulation of bioﬁlm formation is a complex process, and several known regulatory
systems, such as Rbf, SarX, and SarR, also participate in regulation at the transcriptional
level in Staphylococcus species (44). In contrast to the bioﬁlm-related genes (e.g., icaA
and icaR), the spa transcript is upregulated while the hla and sspA transcripts are
downregulated in the teg49 mutant, as supported by RNA-Seq and Northern analyses,
accompanied by slight phenotypic alterations in zones of clearance for hemolysis and
proteases (Table 1). This pattern of regulation is inconsistent with moderate upregulation of RNAIII and mild alteration of the SarA protein level in the teg49 mutant.
Coincidentally, we determined by RNA-Seq that saeRS, a genetic locus not directly
linked to agr and sarA, is signiﬁcantly upregulated in the teg49 mutant. Elevated saeRS
would be expected to result in elevated spa and hla and curtailed sspA expression,
which does not completely explain the teg49 virulence genotype/phenotype that we
have observed. It is conceivable that inactivation of teg49 leads to a combination of
regulatory events (e.g., elevated agr and sae and other factors) that may be able explain
what we observed here in the teg49 mutant.
By setting various criteria, such as minimum read values, discarding phageborne genes, eliminating sarA-regulated genes, and designating 4-fold changes for
signiﬁcance, our RNA-Seq analysis also showed that 133 and 97 genes are upand downregulated, respectively, in the teg49 mutant compared to the wild type.
Several virulence genes, such as those encoding complement inhibitor proteins
(SAOUHSC_02167, SAOUHSC_00401, SAOUHSC_01115, SAOUHSC_02160, map, and
sbi), leukotoxins and superantigen-like proteins, and ﬁbrinogen-binding protein-like
proteins, were altered due to teg49 deletion in the S. aureus genome (Table 2).
It has been shown that antisense base pairing of sbi mRNA (encoding an immunoglobulin binding protein) with SprD, an sRNA expressed from an S. aureus pathogenicity island
(PI⌽), led to an impaired host immune response (30). It would be interesting to investigate the existence of similar mechanisms between teg49-regulated virulence genes
and teg49 in the future. Besides direct base-pairing with target mRNA, several other
mechanisms, including dual-function sRNA that acts as an antisense molecule and
codes for a small peptide (e.g., Hld in RNAIII), have been proposed to act on the same
or other pathway genes, and also riboswitches that exhibit a structured receptor
domain speciﬁcally recognized by a small molecule or metabolite (22, 45). Together, our
data suggest that teg49 sRNA has a regulatory role in S. aureus, but the exact mode of
regulation is yet to be determined.
Overall, our results presented here indicated that teg49 sRNA is processed and
produced from the sarA P3 transcript of the sarA locus and that its stability depends on
the cshA and rnc gene products. Inactivation of teg49 has no major effect on the overall
level of SarA expression, and teg49 appears to be required for the stability of the P3
sarA transcript. Transcriptome proﬁling indicated about 230 genes with at least a 4-fold
change were affected in the teg49 mutant in a sarA-independent manner. The sRNA
teg49 appears to be involved in penicillin-mediated lysis but not in bioﬁlm formation.
A mouse skin abscess model of infection revealed a modest but signiﬁcant reduction
in the bacterial load in the infected skin tissue, thus demonstrating that teg49 plays
a noticeable role in virulence gene regulation in S. aureus. Whether teg49 acts as a
riboswitch in S. aureus is not clear at this point. Whether teg49 can be considered a
target for the development of novel antibacterial compounds to overcome the current
mechanisms of resistance remains to be determined.
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TABLE 3 Bacterial strains and plasmids used in this study
S. aureus strain
or plasmid
Strains
RN4220
SH1000
ALC7907

ALC 2732
AM 1262
ALC8243
ALC8445
ALC8235
ALC8245
NE1494
NE1707
NE0581
NE0259
NE1205
ALC8428
NE0291
NE1079
NE0458
NE1340
NE0501
NE0404
NE0931
Plasmids
pMAD
pEPSA5
pEPSA5::teg49
pSK236
aErm,

Restriction-deﬁcient transformation recipient
Wild-type laboratory strain with a functional rsbU⫹ derivative of the 8325-4 rsbU-defective strain
teg49 mutant of SH1000; chromosomal deletion of 204-bp teg49 from bp 182 to 386 from the ATG
start codon of the sarA gene
ALC7907 containing an empty xylose-inducible vector, pEPSA5
ALC7907 containing pEPSA5 carrying 183-bp teg49 fragment DNA under a xylose-inducible promoter
teg48 mutant of SH1000; chromosomal deletion of 68 bp from the teg48 region of the sarA locus
SH1000 chromosomal P2 promoter mutant at the ⫺35 and ⫺10 sequences of the sarA locus
SH1000 chromosomal P3 promoter mutant at the ⫺35 and ⫺10 sequences of the sarA locus
SH1000 chromosomal P1 promoter mutant at the ⫺35 and ⫺10 sequences of the sarA locus
ALC8373 mutated P3 promoter chromosomally repaired to wild-type P3 promoter at the ⫺35 and
⫺10 sequences of the sarA locus
sarA mutant of SH1000; sarA::erm
Complemented with sarA into the geh locus on chromosome of the sarA mutant of SH1000; sarA::erm
rnc or RNase III mutant of SH1000; rnc::erm
Complemented ALC8243 with pSK236 carrying a 1.5-kb fragment containing the rnc gene region
cshA mutant of SH1000, chsA::kan
hfq mutant of SH1000; hfq::erm
rnc RNase III of JE2 (SAUUSA300_01126)
SAUSA300_1184::erm of JE2
nrdD mutant of JE2; nrdD::erm (SAUUSA_2551)
pnpA mutant of JE2; pnpA::erm (SAUSA300_1167)
nrdG mutant of JE2; nrdG::erm (SAUSA_2550)
rnaseY mutant of JE2 constructed by transduction from Newman rnaseY::erm (SAUSA300_01179)
SAUSA300_2328::erm of JE2
SAUSA300_2021::erm of JE2
xseA mutant JE2; xseA::erm (SAUSA300_1472)
SAUSA300_1692::erm of JE2
rnr mutant of JE2; rnr::erm (SAUSA300_0764)
Endo-RNase L-PSP mutant of JE2; endo-RNase L-PSP::erm (SAUSA300_0474)
SAUSA300_0308::erm of JE2

E. coli-S. aureus shuttle vector containing temperature-sensitive origin of replication, bgaB; Ermr Apr
E. coli-S. aureus xylose-inducible shuttle vector containing xylose-inducible promoter for conditional
expression of the desired gene; Cmr Apr
pEPSA5 containing 196-bp teg49 sRNA region
Shuttle vector containing pUC19 cloned into the HindIII site of pC194

Reference
or source
52
53
This study
This
32
This
This
This
This
This
14
14
This
This
This
This
33
33
33
33
33
This
33
33
33
33
33
33
33

study
study
study
study
study
study

study
study
study
study

study

47
32
32
14

erythromycin; Ap, chloramphenicol; Cm, chloramphenicol.

MATERIALS AND METHODS
Bacterial strains, plasmids, and culture media. The bacterial strains and plasmids used in this study
are listed in Table 3. S. aureus strain RN4220, a restriction-deﬁcient derivative of strain 8325-4, was used
as the initial recipient for the transformation of plasmid constructs. The S. aureus strains were grown in
tryptic soy broth (TSB) or on TSA supplemented with antibiotics when necessary (5 g/ml of erythromycin and 10 g/ml of chloramphenicol). The cells were grown with continuous aeration in a shaker at
either 37°C or the required permissive temperatures. Luria-Bertani (LB) broth or agar, supplemented with
suitable antibiotics when necessary (100 g/ml of ampicillin and 40 g/ml of kanamycin), was used for
growing E. coli. Growth was monitored by measuring changes in turbidity at 600 nm in a spectrophotometer (Spectronic 20D).
Genetic manipulation. Standard procedures for DNA manipulations were performed using routine
cloning procedures (46). Mutagenesis of various sarA promoters (P2, P3, and P1) was performed using
pCR2.1 containing a P2 sarA fragment ﬂanking BamHI sites at both ends as a template and various
mutagenized primer pairs as listed in Table S1 in the supplemental material (P2 sarA, ⫺35 AGCAAA to
CCCCAC and ⫺10 TAATAT to CCACTC; P3 sarA, ⫺35 AGTGAT to CCCAAA and ⫺10 GGGTAT to CCACTC;
and P1 sarA, ⫺35 TTTACT to CCCCAA and ⫺10 TATAAT to CCACTC). PCR-mediated plasmid mutagenesis
was performed using Pfu and Taq polymerases, and clones were authenticated by DNA sequencing. The
1.5-kb BamHI fragments containing various individual promoter mutations were cloned into the BamHI
site of the temperature-sensitive shuttle vector pMAD (47). The recombinant pMAD plasmids were ﬁrst
electroporated into strain RN4220 and then into S. aureus strain SH1000 for construction of various
mutants. Construction, selection, and authentication of the putative mutants were performed as described previously (46, 47). These mutant strains were labeled ALC8372 (P2m), ALC8373 (P3m), and
ALC8374 (P1m) for sarA P2, P3, and P1 promoter knockout mutants, respectively. To restore the promoter
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in the P3m promoter knockout strain, a 1.5-kb fragment containing the native P3 sarA fragment was
cloned into pMAD and transformed into strain ALC8373 to construct a revertant P3m/P3wt strain,
ALC8441, following the same procedure as previously described for mutant strain construction. Construction of rnc::erm (ALC8243), cshA::kan (ALC8235), hfq::erm (ALC8245) of SH1000 and rny::erm
(ALC8428) of JE2 was performed by phage transduction from the respective Newman background
mutant strains. To complement the rnc mutation, a 1.5-kb DNA fragment encompassing the rnc gene
region was cloned in shuttle plasmid pSK236 and transformed into ALC8243 (rnc::erm) to construct a
trans-complemented strain (ALC8445).
Construction of the teg49 mutant was performed using the same PCR-mediated method of mutagenesis with the primers used in Table S1 in the supplemental material to delete 204 bp from bp 385
to 182 upstream from the ATG start codon of the sarA gene using pCR2.1 carrying a 2.3-kb fragment
encompassing the sarA locus as the template. A 2.2-kb DNA fragment containing the deletion was cloned
into pMAD to construct the teg49 deletion mutant (ALC7907), as described previously for the construction of various promoter mutants. Final authentication of various mutant strains was performed by DNA
sequencing of the PCR products and Northern hybridization. Complementation of the teg49 mutant was
performed in trans using pEPSA5::teg49 in the presence of 2% xylose in broth (32).
Isolation of total cellular RNA and Northern blot hybridization. Isolation of total cellular RNA
from various growth phases and subsequent analysis by Northern blot hybridization were performed as
described previously (46). DNA fragments containing the open reading frames of sarA, icaA, icaR, spa, hla,
and sspA or sRNA teg49, teg23, and teg35 and other RNA-Seq-validated genes were ampliﬁed by PCR or
excised from the plasmids containing the desired genes with restriction endonucleases and then gel
puriﬁed. For detection of speciﬁc transcripts, gel-puriﬁed DNA probes were radiolabeled with [␣-32P]dCTP
by using the random-primed DNA-labeling kit (Roche Diagnostics GmbH) and hybridized under aqueousphase conditions at 65°C. The blots were subsequently washed, exposed to a phosphorimager screen,
and scanned. Each of the experiments was repeated at least three times independently.
Western blotting and immunodetection. Whole-cell extracts from S. aureus wild-type SH1000 or
various mutant strains were prepared from cells grown to different growth phases, as described
previously (46). The concentration of total proteins from clear lysates was determined by using a Pierce
bicinchoninic acid (BCA) protein assay kit (Thermo Scientiﬁc, USA) using bovine serum albumin as
the standard. Western blotting and detection with primary antibody (anti-SarA) and donkey anti-mouse
secondary antibody conjugated with horseradish peroxidase (HRP) and enhanced chemiluminescence
(ECL) Western blotting substrate (Thermo Scientiﬁc) were performed as described previously (46). The
experiments were repeated at least three times independently.
Bioﬁlm assay. Quantiﬁcation of bioﬁlm formation on abiotic surfaces was performed as described
previously (35, 48). Brieﬂy, S. aureus strains grown overnight in TSB were diluted (1:50) in TSB supplemented with 0.25% glucose. This cell suspension was used to inoculate sterile 96-well U-bottom
polystyrene microtiter plates (Costar, Corning Inc., USA) in triplicate. After 24 h of incubation at 37°C, the
wells were gently washed three times with water, air dried in an inverted position, and stained with 0.1%
crystal violet dye in water for 15 min at room temperature. The wells were rinsed 3 or 4 times by
submerging them in water, dried for several hours to overnight in an inverted position, and solubilized
in 30% acetic acid in water for 15 min. The solubilized dye was transferred to ﬂat-bottom microtiter
plates, and the absorbance at 550 nm was determined (Inﬁnite M1000 Pro; Tecan, Austria). Each assay
was repeated at least three times in separate experiments.
Protease and hemolysin assays. A protease assay for all the tested strains was performed using TSA
supplemented with 5% skim milk. Similarly, a hemolysis assay was done using 5% sheep blood TSA plates
(Remel, Kansas, USA). Equal volumes (3 l) of equivalent optical density (OD600) of various strains were
spotted onto plates in triplicate and incubated for 20 to 36 h at 37°C. The zones of clearance from three
independent experiments were measured and compared.
RNA-Seq experiments. Samples for RNA-Seq were prepared from the following strains: the wild-type
SH1000, its isogenic derivative teg49 mutant (ALC7907), and the isogenic sarA mutant (ALC2732). Brieﬂy,
overnight cultures were diluted 1:100 in fresh TSB (initial OD600, about 0.04 to 0.05) and grown at 37°C
for 3 h. Two replicate cultures for each sample were grown, and total cellular RNAs from two biological
replicates were extracted as described previously (32). RNA was quantiﬁed by using Qubit (Life Technologies), and RNA integrity was assessed with a 2100 Bioanalyzer (Agilent Technologies). A 1-g amount
of total RNA was ribodepleted with a bacterial Ribo-Zero kit from Illumina. A TruSeq RNA stranded kit
from Illumina was used for library preparation. The library quantity was measured with Qubit, and quality
was assessed on a Tapestation on a DNA high-sensitivity chip (Agilent Technologies). The libraries were
pooled at equimolarity and loaded at 2 nM for clustering. Oriented 50-base single-read sequencing was
performed on an Illumina HiSeq 4000 sequencer, yielding a minimum of 9 million mapped reads per
sample. Final RNA-Seq analysis and data analysis were carried out using previously described procedures
(32). Statistical analyses were done in R v3.2.3 using the edgeR package (49) following a bioinformatics
protocol described previously (50). Brieﬂy, genes whose expression was not at least one read per million
in two replicates of the samples were ﬁltered out. Counts of the retained genes were normalized
according to the weighted trimmed mean of M values (TMM) method. Read counts for each transcript
in each sample were modeled according to a negative binomial (NB) distribution. Finally, pairwise
comparisons between read libraries from various strains were performed with the exact test (49, 50) to
detect differentially expressed transcripts. P values were corrected according to the false-discovery rate
(FDR).
qRT-PCR analysis. qRT-PCR was performed as previously described (34). Brieﬂy, cDNA was obtained
using GoScript cDNA synthesis mix (Promega, USA) and DNase I-treated puriﬁed total RNA as a template.
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Maxima SYBR green/ROX qRT-PCR master mix (Thermo Scientiﬁc) was used to generate standard curves
for the cDNA concentration/crossing point (Cp) for the target genes and the reference gene, gyrB. The
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a starting OD650 of 0.05. Penicillin G was added to a concentration of 0.04 g/ml (the MIC determined
for strain SH1000 is ⱕ0.0039 g/ml) at the early exponential phase of growth (OD650 ⬇ 0.25). Cultures
were incubated at 37°C with shaking, and the OD650 was measured every hour for 7 h.
Murine cutaneous model of infection. A murine skin infection model was used to determine the
effect of the teg49 mutation on virulence in the SH1000 background. Animal experiments were
performed in accordance with a protocol approved by the Institutional Animal Care and Use Committee
at the Geisel School of Medicine at Dartmouth, Hanover, NH. Female BALB/c mice were held, shaved on
the back, and inoculated by subcutaneous injection in the right ﬂank with 1 ⫻ 108 S. aureus bacteria in
50 l of PBS, using a 23-gauge needle. The mice were weighed before inoculation, and abscess formation
was monitored at 24-h intervals for 5 days. The sizes of the abscesses were calculated using a standard
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as present or absent. Six mice per group were used for each bacterial strain or control group. After 5 days
of infection, at which time abscesses were evident in most mice, the mice were sacriﬁced and abscess
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triplicate in mannitol salt agar for incubation at 37°C for 48 h to derive the number of CFU per gram of
abscess tissue for various strains.
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mean unless otherwise indicated. All data were analyzed using Graph Pad Prism 7. The data represent
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unless otherwise indicated. For normally distributed data, comparisons were tested with Student’s t test.
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